Kemula Pierre Thadee Victor

EDGAR CIK 0002119332

Agomab Therapeutics NV - AGMB

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
Chief Financial Officer
Direct Buys
1
$85,940
10,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/06/2026
10/07/2026
Buy
10,000 @ $8.59
 $85,940 10,000 (100.00%) Direct